[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100534433":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":7,"locations":8,"responsibleParty":28,"collaborators":7,"id":30,"slug":7,"hasResults":31,"nctId":32,"briefTitle":33,"officialTitle":33,"acronym":7,"eligibilityCriteria":34,"healthyVolunteers":35,"sex":36,"minAge":37,"maxAge":38,"enrollmentInfo":39,"targetDuration":7,"studyType":42,"phases":7,"briefSummary":43,"conditions":44,"keywords":7,"overallStatus":11,"whyStopped":7,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":55},{"fullName":5,"class":6},"CorEvitas","NETWORK",null,[9],{"facility":10,"status":11,"city":12,"state":13,"zip":14,"country":15,"cosmosGeoPoint":16,"geoPoint":21,"contacts":22},"CorEvitas, LLC","RECRUITING","Waltham","Massachusetts","02451","United States",{"type":17,"coordinates":18},"Point",[19,20],-71.23561,42.37649,{"lat":20,"lon":19},[23],{"name":24,"role":25,"phone":26,"phoneExt":7,"email":27},"Cathy Cheney","CONTACT","508-555-1212","corevitasregistrytrials@corevitas.com",{"type":29,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100534433",false,"NCT06238765","CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry","Inclusion Criteria:\n\n* To be eligible to participate in this registry, an individual must meet all the following criteria:\n\n  1. Has been diagnosed with moderate to severe atopic dermatitis by a dermatologist or a qualified healthcare provider\n  2. Is 10 - 15 years of age at the time of enrollment.\n  3. Subject has initiated or is initiating an enrollment-eligible medication at the time of enrollment\n\n     Exclusion Criteria:\n* An individual who meets any of the following criteria will be excluded from participation in the registry:\n\n  1. Is participating or planning to participate in a blinded clinical trial for an AD drug.\n  2. Is unwilling or unable to provide standing height measurements.",true,"ALL","10 Years","15 Years",{"count":40,"type":41},1500,"ESTIMATED","OBSERVATIONAL","Prospective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.",[45],"Atopic Dermatitis","2026-06-25",{"date":48,"type":49},"2026-06-29","ACTUAL",{"date":51,"type":49},"2023-12-02",{"date":53,"type":41},"2099-12-31",{"name":5,"class":6},1]